Announcements

Homepage

2022-12-08

Welcome to the Journal of Pharmacovigilance & Drug Safety (JPDS).

Journal of Pharmacovigilance & Drug Safety is a peer-reviewed open-access international medical research journal that publishes original research work in the form of Full Length Papers, Review Articles, Case Reports, Letter to Editor, Short communications, Drug Updates. The journal is printed Two times a year. The language of the journal is English.

The journal is available online since 2019. 

Subject/Areas of Publication:

Journal of Pharmacovigilance & Drug Safety (JPDS) is the official journal of the Society of Pharmacovigilance India. The journal includes all the articles related to Medical Sciences especially:   

  • Pharmacovigilance signal
  • Pharmacovigilance Data Management
  • Adverse Drug Reaction
  • Adverse Events
  • Risk assessment and management
  • Drug Informatics
  • Epidemiological Methods
  • Clinical drug manifestations of adverse drug reactions
  • Post marketing surveillance
  • Medical evaluation of adverse events
  • Pharmacogenetics
  • Pharmacogenomics
  • Materiovigilance
  • Evopharmacovigilance
  • Herbal drugs safety

 

 

Read more about Homepage

Current Issue

Volume 21 | Issue 1 | 2024
Published: 2024-06-01

REVIEW ARTICLES

CASE REPORT

CONFERENCE PROCEEDINGS

View All Issues

In the modern era of clinical application of knowledge of pharmacology, it is a big dilemma in hoosing between the good and the best drug. In making a decision for treatment planning clinician must consider the additional features of local and systemic issues, patient's economic status as well as potential adverse effect of the drug.

There are large number of drug trial going on world wide to observe the effect of a particular drug or a molecule. However, the scenario has changed drastically in last 20 years. What it was with the western/ developed world is now shifting over to developing world.

India is set to grab clinical trial business, making the subcontinent world's preferred destination for clinical trials. The big reason being low cost of trial along with friendly drug control system with competent work force and patient availability. Indian investigators and clinical trial research professionals have already demonstrated their medical and scientific skills in various global clinical trials. It is time now to capitalize on this opportunity. Indian investigators and research professionals can prove their ability and show to the world and register their presence now as well as for future.